Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Zacharias Wijfjes"'
Autor:
Carl G Figdor, I Jolanda M de Vries, Camille Le Gall, Anna Cammarata, Lukas de Haas, Iván Ramos-Tomillero, Jorge Cuenca-Escalona, Kayleigh Schouren, Zacharias Wijfjes, Anouk M D Becker, Johanna Bödder, Yusuf Dölen, Georgina Flórez-Grau, Martijn Verdoes
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 4 (2022)
Externí odkaz:
https://doaj.org/article/cb3adf0d6b7342ed8ed2d2b302e22501
Autor:
Marit J. van Elsas, Johan M. S. van der Schoot, Alexander Bartels, Kas Steuten, Duco van Dalen, Zacharias Wijfjes, Carl G. Figdor, Thorbald van Hall, Sjoerd H. van der Burg, Martijn Verdoes, Ferenc A. Scheeren
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 15, p 8707 (2022)
Regulatory T cells (Tregs) are major drivers behind immunosuppressive mechanisms and present a major hurdle for cancer therapy. Tregs are characterized by a high expression of CD25, which is a potentially valuable target for Treg depletion to allevia
Externí odkaz:
https://doaj.org/article/9b99950f014f4b1bb3ab28ac5b6c67cb
Autor:
Kimberly M. Bonger, Camille M. Le Gall, Melek Parlak Khalily, Martijn Verdoes, Iván Ramos-Tomillero, Liyan Smeding, Carl G. Figdor, Johan M.S. van der Schoot, Anna Cammarata, Zacharias Wijfjes, Ferenc A. Scheeren, Floris J. van Dalen, Duco van Dalen
Publikováno v:
Bioconjugate Chemistry
Bioconjugate Chemistry, 32(2), 301-310. AMER CHEMICAL SOC
Bioconjugate Chemistry, 32, 2, pp. 301-310
Bioconjugate Chemistry, 32, 301-310
bioRxiv
Bioconjugate Chemistry, 32(2), 301-310. AMER CHEMICAL SOC
Bioconjugate Chemistry, 32, 2, pp. 301-310
Bioconjugate Chemistry, 32, 301-310
bioRxiv
I.AbstractFunctionalized antibodies and antibody fragments have found applications in the fields of biomedical imaging, theragnostics, and antibody-drug conjugates (ADC). Antibody functionalization is classically achieved by coupling payloads onto ly
Autor:
Camille Le Gall, Anna Cammarata, Lukas de Haas, Iván Ramos-Tomillero, Jorge Cuenca-Escalona, Kayleigh Schouren, Zacharias Wijfjes, Anouk M D Becker, Johanna Bödder, Yusuf Dölen, I Jolanda M de Vries, Carl G Figdor, Georgina Flórez-Grau, Martijn Verdoes
Publikováno v:
Journal for Immunotherapy of Cancer, 10, 4
Journal for ImmunoTherapy of Cancer
Journal for Immunotherapy of Cancer, 10
Journal for ImmunoTherapy of Cancer
Journal for Immunotherapy of Cancer, 10
BackgroundType 1 conventional dendritic cells (cDC1s) are characterized by their ability to induce potent CD8+T cell responses. In efforts to generate novel vaccination strategies, notably against cancer, human cDC1s emerge as an ideal target to deli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f4851762718d0b72450b725e0e60926
https://doi.org/10.1136/jitc-2021-004309
https://doi.org/10.1136/jitc-2021-004309